DLB · Dolby Laboratories, Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q2 '26 | Q1 '26 | Q3 '25 | Q2 '25 | Q1 '25 | Q3 '24 | Q2 '24 | Q1 '24 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $395.63M | $346.71M | $315.55M | $369.56M | $357.00M | $288.82M | $364.52M | $315.57M | $298.37M | $375.89M |
| Cost of Revenue | $44.73M | $43.21M | $44.00M | $35.84M | $40.77M | $35.66M | $38.78M | $32.06M | $41.52M | $41.05M |
| Gross Profit | $350.90M | $303.50M | $271.54M | $333.72M | $316.23M | $253.16M | $325.75M | $283.51M | $256.86M | $334.84M |
| R&D | $63.65M | $69.08M | $65.98M | $61.71M | $66.64M | $65.50M | $62.49M | $67.03M | $68.70M | $67.95M |
| SG&A | $75.95M | $70.24M | $72.31M | $70.42M | $70.09M | $69.28M | $66.74M | $65.17M | $69.95M | $61.94M |
| Total Operating Expenses | $237.95M | $241.34M | $223.91M | $225.96M | $236.34M | $216.37M | $216.78M | $217.29M | $240.92M | $225.62M |
| D&A | - | $24.14M | - | - | $22.36M | - | - | $17.87M | - | - |
| Operating Income | $112.95M | $62.16M | $47.64M | $107.76M | $79.88M | $36.78M | $108.97M | $66.22M | $15.94M | $109.22M |
| Interest Expense | - | - | - | - | - | - | - | - | $114.0K | ($34.0K) |
| Income Tax | $24.25M | $17.92M | $8.97M | $28.02M | $17.98M | $10.51M | $23.53M | $13.25M | $7.35M | $21.40M |
| Net Income | $94.92M | $53.33M | $46.07M | $91.79M | $67.82M | $38.44M | $97.83M | $66.98M | $16.40M | $95.70M |
| EPS - Basic | $1.00 | $0.56 | $0.48 | $0.95 | $0.71 | $0.40 | $1.02 | $0.70 | $0.17 | $1.00 |
| EPS - Diluted | $0.99 | $0.55 | $0.48 | $0.94 | $0.70 | $0.40 | $1.01 | $0.69 | $0.17 | $0.98 |
Balance Sheet
| Line item | Q2 '26 | Q1 '26 | Q3 '25 | Q2 '25 | Q1 '25 | Q3 '24 | Q2 '24 | Q1 '24 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $594.28M | $643.85M | $701.89M | $626.55M | $520.82M | $482.05M | $709.53M | $656.82M | $745.36M | $688.44M |
| Accounts Receivable | $391.29M | $373.09M | $331.10M | $314.11M | $339.30M | $315.46M | $282.13M | $293.23M | $262.25M | $283.31M |
| Inventory | $31.93M | $31.26M | $30.42M | $34.59M | $31.83M | $33.73M | $35.80M | $37.57M | $35.62M | $30.35M |
| Accounts Payable | $20.69M | $8.67M | $17.84M | $17.29M | $11.55M | $17.38M | $19.73M | $14.39M | $20.93M | $17.17M |
| Current Assets | $1.41B | $1.41B | $1.39B | $1.39B | $1.29B | $1.19B | $1.55B | $1.45B | $1.49B | $1.46B |
| Total Assets | $3.25B | $3.19B | $3.23B | $3.23B | $3.16B | $3.11B | $3.04B | $2.94B | $2.98B | $2.84B |
| Current Liabilities | $474.61M | $443.51M | $437.79M | $457.49M | $441.88M | $417.84M | $442.90M | $394.10M | $422.23M | $314.01M |
| Long-term Debt | - | - | - | - | - | - | - | - | - | - |
| Total Liabilities | $622.36M | $589.25M | $595.81M | $646.02M | $641.57M | $623.03M | $607.04M | $573.22M | $607.58M | $480.14M |
| Stockholders' Equity | $2.62B | $2.59B | $2.62B | $2.57B | $2.51B | $2.48B | $2.42B | $2.35B | $2.36B | $2.35B |
| Retained Earnings | $2.63B | $2.60B | $2.63B | $2.60B | $2.54B | $2.50B | $2.45B | $2.37B | $2.39B | $2.38B |
Cash Flow
| Line item | Q2 '26 | Q1 '26 | Q3 '25 | Q2 '25 | Q1 '25 | Q3 '24 | Q2 '24 | Q1 '24 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | $54.80M | - | - | $106.78M | - | - | $8.41M | - | - |
| Investing Cash Flow | - | $1.25M | - | - | ($8.14M) | - | - | $633.0K | - | - |
| Financing Cash Flow | - | ($121.83M) | - | - | ($57.57M) | - | - | ($125.14M) | - | - |
| CapEx | - | $4.63M | - | - | $6.78M | - | - | $6.10M | - | - |
| Free Cash Flow | - | $50.17M | - | - | $100.00M | - | - | $2.31M | - | - |
Ratios
| Metric | Q2 '26 | Q1 '26 | Q3 '25 | Q2 '25 | Q1 '25 | Q3 '24 | Q2 '24 | Q1 '24 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | 88.7% | 87.5% | 86.1% | 90.3% | 88.6% | 87.7% | 89.4% | 89.8% | 86.1% | 89.1% |
| Operating margin | 28.5% | 17.9% | 15.1% | 29.2% | 22.4% | 12.7% | 29.9% | 21.0% | 5.3% | 29.1% |
| EBITDA margin | - | 24.9% | - | - | 28.6% | - | - | 26.6% | - | - |
| Net margin | 24.0% | 15.4% | 14.6% | 24.8% | 19.0% | 13.3% | 26.8% | 21.2% | 5.5% | 25.5% |
| Free cash flow margin | - | 14.5% | - | - | 28.0% | - | - | 0.7% | - | - |
| FCF / Net income | - | 0.94 | - | - | 1.47 | - | - | 0.03 | - | - |
| R&D / Revenue | 16.1% | 19.9% | 20.9% | 16.7% | 18.7% | 22.7% | 17.1% | 21.2% | 23.0% | 18.1% |
| SG&A / Revenue | 19.2% | 20.3% | 22.9% | 19.1% | 19.6% | 24.0% | 18.3% | 20.6% | 23.4% | 16.5% |
| Effective tax rate | 20.3% | 25.2% | 16.3% | 23.4% | 21.0% | 21.5% | 19.4% | 16.5% | 31.0% | 18.3% |
| Return on assets | 2.9% | 1.7% | 1.4% | 2.8% | 2.1% | 1.2% | 3.2% | 2.3% | 0.6% | 3.4% |
| Return on equity | 3.6% | 2.1% | 1.8% | 3.6% | 2.7% | 1.6% | 4.0% | 2.9% | 0.7% | 4.1% |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 2.98 | 3.17 | 3.17 | 3.04 | 2.91 | 2.86 | 3.50 | 3.68 | 3.52 | 4.66 |
| Quick ratio | 2.91 | 3.10 | 3.10 | 2.96 | 2.84 | 2.78 | 3.42 | 3.59 | 3.44 | 4.56 |
| Cash ratio | 1.25 | 1.45 | 1.60 | 1.37 | 1.18 | 1.15 | 1.60 | 1.67 | 1.77 | 2.19 |
| Leverage | ||||||||||
| Debt / Equity | - | - | - | - | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | - | - | - | - | - | - | - | - | 139.8x | -3212.5x |
| Equity multiplier | 1.24 | 1.23 | 1.23 | 1.25 | 1.26 | 1.26 | 1.26 | 1.25 | 1.27 | 1.21 |
| Liabilities / Assets | 0.19 | 0.18 | 0.18 | 0.20 | 0.20 | 0.20 | 0.20 | 0.20 | 0.20 | 0.17 |
| Efficiency | ||||||||||
| Asset turnover | 0.12 | 0.11 | 0.10 | 0.11 | 0.11 | 0.09 | 0.12 | 0.11 | 0.10 | 0.13 |
| Inventory turnover | 1.40 | 1.38 | 1.45 | 1.04 | 1.28 | 1.06 | 1.08 | 0.85 | 1.17 | 1.35 |
| Days sales outstanding | 361d | 393d | 383d | 310d | 347d | 399d | 283d | 339d | 321d | 275d |
| Days inventory outstanding | 261d | 264d | 252d | 352d | 285d | 345d | 337d | 428d | 313d | 270d |
| Days payable outstanding | 169d | 73d | 148d | 176d | 103d | 178d | 186d | 164d | 184d | 153d |
| Cash conversion cycle | 453d | 584d | 487d | 486d | 528d | 566d | 434d | 603d | 450d | 392d |
| Valuation | ||||||||||
| P / E | 58.6x | 119.5x | 150.8x | 85.0x | 112.1x | 189.0x | 82.9x | 124.9x | 466.2x | 87.2x |
| P / B | 2.1x | 2.4x | 2.7x | 3.0x | 3.0x | 3.0x | 3.4x | 3.6x | 3.3x | 3.5x |
| P / S | 14.0x | 18.3x | 22.2x | 21.1x | 21.4x | 25.4x | 22.3x | 26.6x | 25.9x | 22.1x |
| EV / EBITDA | - | 66.0x | - | - | 69.5x | - | - | 92.0x | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | 7.1% | -2.9% | 9.3% | 1.4% | 13.1% | -3.2% | -3.0% | -5.8% | 3.0% | 12.4% |
| Revenue CAGR (3y) | 1.7% | 1.2% | 2.9% | 3.4% | 0.5% | 0.2% | 4.5% | -6.8% | 6.5% | 2.2% |
| Revenue CAGR (5y) | 4.4% | -2.3% | 5.0% | 1.0% | 4.1% | -0.9% | 1.5% | 0.9% | -1.2% | 4.5% |
| Gross profit growth (YoY) | 5.1% | -4.0% | 7.3% | 2.4% | 11.5% | -1.4% | -2.7% | -5.6% | 1.3% | 12.0% |
| Operating income growth (YoY) | 4.8% | -22.2% | 29.5% | -1.1% | 20.6% | 130.8% | -0.2% | -29.6% | -65.0% | 152.0% |
| Net income growth (YoY) | 3.4% | -21.4% | 19.8% | -6.2% | 1.3% | 134.4% | 2.2% | -15.6% | -58.6% | 160.6% |
| EPS growth (YoY) | 5.3% | -21.4% | 20.0% | -6.9% | 1.4% | 135.3% | 3.1% | -15.9% | -56.4% | 172.2% |
| EPS CAGR (3y) | 0.3% | -12.5% | 7.2% | 37.7% | -3.1% | -8.4% | 11.4% | -19.0% | -36.4% | 4.5% |
| EPS CAGR (5y) | 6.3% | -15.8% | -6.2% | 1.8% | 8.3% | 1.0% | 7.6% | -5.8% | -26.3% | 8.2% |
| FCF growth (YoY) | - | -49.8% | - | - | 4229.0% | - | - | -95.3% | - | - |
| FCF CAGR (5y) | - | -5.5% | - | - | 66.7% | - | - | -43.0% | - | - |
| Book value growth (YoY) | 1.7% | 3.4% | 5.9% | 6.3% | 6.9% | 5.2% | 3.0% | 2.5% | 4.8% | -9.6% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-09-26.
Business segments
$1.35B totalReportable Segment$1.35B · 100.0%
Product / service
$2.60B totalTotal Licensing Revenue$1.25B · 48.1%
Licensing Brodcast Revenue$428.47M · 16.5%
Licensing Mobile Revenue$268.57M · 10.3%
Licensing Other Revenue$248.38M · 9.6%
Licensing PCRevenue$151.89M · 5.8%
Licensing CERevenue$150.70M · 5.8%
Products And Services$101.11M · 3.9%
Geographic
$1.35B totalNon Us$852.14M · 63.2%
US$496.99M · 36.8%
Peer comparison
Same SIC group: Patent Owners & Lessors
Comparing Dolby Laboratories against the 5 most active filers in the same SIC group.
Dividends
$1.41/share trailing 12 months · +9.3% YoY
| Ex-date | Per share |
|---|---|
| May 12, 2026 | $0.3600 |
| Feb 10, 2026 | $0.3600 |
| Dec 2, 2025 | $0.3600 |
| Aug 12, 2025 | $0.3300 |
| May 13, 2025 | $0.3300 |
| Feb 11, 2025 | $0.3300 |
| Dec 3, 2024 | $0.3300 |
| Aug 19, 2024 | $0.3000 |
| May 13, 2024 | $0.3000 |
| Feb 12, 2024 | $0.3000 |
| Nov 27, 2023 | $0.3000 |
| Aug 11, 2023 | $0.2700 |
| May 15, 2023 | $0.2700 |
| Feb 13, 2023 | $0.2700 |
| Nov 29, 2022 | $0.2700 |
| Aug 22, 2022 | $0.2500 |
| May 16, 2022 | $0.2500 |
| Feb 15, 2022 | $0.2500 |
| Nov 29, 2021 | $0.2500 |
| Aug 10, 2021 | $0.2200 |
| May 14, 2021 | $0.2200 |
| Feb 8, 2021 | $0.2200 |
| Nov 23, 2020 | $0.2200 |
| Aug 14, 2020 | $0.2200 |